Elevai Labs (ELAB) News Today → You missed the class - here’s your second chance (From DTI) (Ad) Free ELAB Stock Alerts $0.69 +0.04 (+6.20%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 12:06 AM | investorplace.comELAB Stock Earnings: Elevai Labs Reported Results for Q1 2024May 15, 2024 | finance.yahoo.comElevai Labs Inc. Reports First Quarter 2024 Financial ResultsMay 13, 2024 | americanbankingnews.comElevai Labs, Inc.'s (NASDAQ:ELAB) Lock-Up Period To End on May 20thMay 2, 2024 | globenewswire.comElevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of ObesityMay 1, 2024 | globenewswire.comElevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome SkincareMay 1, 2024 | bizjournals.comElevai Labs in deal to develop co-treatments for weight-loss drugsMay 1, 2024 | globenewswire.comElevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity TreatmentsApril 29, 2024 | globenewswire.comElevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue CommitmentsApril 25, 2024 | seekingalpha.comELAB Elevai Labs, Inc.April 22, 2024 | globenewswire.comELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 MonthsApril 20, 2024 | finance.yahoo.comElevai Labs, Inc. (ELAB)April 2, 2024 | investorplace.comELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023March 29, 2024 | globenewswire.comElevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial ResultsMarch 20, 2024 | investing.comELEVAI launches consumer skincare portalMarch 18, 2024 | globenewswire.comElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical MarketFebruary 2, 2024 | finanznachrichten.deFibroBiologics Announces Anticipated Listing DayFebruary 1, 2024 | investorplace.comWhy Is Elevai Labs (ELAB) Stock Up 57% Today?January 24, 2024 | finance.yahoo.comELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark OfficeJanuary 17, 2024 | msn.comELEVAI LABS reports preliminary total net revenue for 2023 of over $1.635MJanuary 17, 2024 | finance.yahoo.comELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global ReachJanuary 16, 2024 | investorplace.comWhy Is Elevai Labs (ELAB) Stock Up Today?January 16, 2024 | finanznachrichten.deElevai Labs Inc.: ELEVAI Labs, Inc. Acquires Worldwide License Agreement for Proprietary Stem Cell Manufacturing TechnologyJanuary 16, 2024 | marketwatch.comElevai Labs Shares Double After Licensing Deal With INmune BioJanuary 2, 2024 | finance.yahoo.comELEVAI LABS, Inc. to Participate in Upcoming Aesthetic Industry ConferencesDecember 12, 2023 | investorplace.comELAB Stock Earnings: Elevai Labs Reported Results for Q3 2024December 11, 2023 | finance.yahoo.comElevai Labs Inc Announces Financial Results for the Quarter Ended September 30, 2023December 8, 2023 | morningstar.comElevai Labs Inc ELABDecember 7, 2023 | finance.yahoo.comELEVAI Labs, Inc. Expands International Distribution into EuropeNovember 30, 2023 | marketbeat.comTrading was temporarily halted for "ELAB" at 10:11 AM with a stated reason of "LULD pause."November 30, 2023 | marketbeat.comTrading was temporarily halted for "ELAB" at 10:11 AM with a stated reason of "LULD pause."November 29, 2023 | finance.yahoo.comElevai Labs Enters into Licensing Agreement with Yuva Biosciences to Combine Exosome and Mitochondrial Technologies to Develop New Aesthetics ProductsNovember 27, 2023 | investing.comElevai Labs Inc (ELAB)November 27, 2023 | marketbeat.comTrading was temporarily halted for "ELAB" at 10:11 AM with a stated reason of "LULD pause."November 24, 2023 | finance.yahoo.comELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public OfferingNovember 22, 2023 | marketwatch.comElevai Labs Prices 1.5 Million-Share IPO at $4 a ShareNovember 22, 2023 | finance.yahoo.comElevai Labs, Inc. Common Stock (ELAB)November 22, 2023 | msn.comSkincare company Elevai Labs sees stock dip 5% following $6M IPONovember 21, 2023 | marketbeat.comTrading was temporarily halted for "ELAB" at 10:11 AM with a stated reason of "LULD pause." Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover ELAB Media Mentions By Week ELAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELAB News Sentiment▼0.590.42▲Average Medical News Sentiment ELAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELAB Articles This Week▼61▲ELAB Articles Average Week Get Elevai Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ELAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ABVC News AVTX News ERNA News AKTX News MNPR News MIRA News GHSI News MBRX News AEZS News ADXN News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELAB) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaUrgent Nvidia WarningAltimetryDems have chosen Biden replacement?Paradigm PressMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elevai Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
